NCT07376148 Fractional CO2 Laser-assisted Delivery of Hyaluronic Acid, Ascorbic Acid and Sodium DNA For Enhancing Facial Skin Quality in Individuals Over the Age of 30
| NCT ID | NCT07376148 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Instituto de Oftalmología Fundación Conde de Valenciana |
| Condition | Skin Quality Improvement |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-11-07 |
| Primary Completion | 2026-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 30 participants in total. It began in 2025-11-07 with a primary completion date of 2026-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluate the effectiveness of topical hyaluronic acid, ascorbic acid, and sodium DNA following ablative fractional laser treatment in objectively reversing facial skin alterations induced by photoaging.
Eligibility Criteria
Inclusion Criteria: * Male and female subjects, over 30 years of age, with moderate skin changes associated with elasticity, wrinkles, roughness, pigmentation, erythema, and pore size; with at least 12 points on the SASSQ scale. Fitzpatrick skin type I-III. Participants who agree to take part in the protocol Exclusion Criteria: * Fitzpatrick skin type IV-VI. Local infections or inflammatory disorders.. Neoplasms suspected of being malignant. Allergy to hyaluronic acid, ascorbic acid, and sodium DNA. Hypersensitivity to fractional CO2 laser. Pregnancy or breastfeeding. Local or systemic adverse reaction
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07376148 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, studying Skin Quality Improvement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07376148 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07376148 currently recruiting?
Yes, NCT07376148 is actively recruiting participants. Contact the research team at db.mejia@outlook.com for enrollment information.
Where is the NCT07376148 trial being conducted?
This trial is being conducted at Mexico City, Mexico.
Who is sponsoring the NCT07376148 clinical trial?
NCT07376148 is sponsored by Instituto de Oftalmología Fundación Conde de Valenciana. The trial plans to enroll 30 participants.